Recombinant human CD80 protein (Active) is a Human Fragment protein, in the 35 to 242 aa range, expressed in HEK 293, with >95% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, ELISA, HPLC, FuncS.
V I H V T K E V K E V A T L S C G H N V S V E E L A Q T R I Y W Q K E K K M V L T M M S G D M N I W P E Y K N R T I F D I T N N L S I V I L A L R P S D E G T Y E C V V L K Y E K D A F K R E H L A E V T L S V K A D F P T P S I S D F E I P T S N I R R I I C S T S G G F P E P H L S W L E N G E E L N A I N T T V S Q D P E T E L Y A V S S K L D F N M T T N H S F M C L I K Y G H L R V N Q T F N W N T T K Q E H F P D N
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application ELISA | Reactivity Reacts | Dilution info - | Notes - |
Application HPLC | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Select an associated product type
Costimulatory molecule that belongs to the immunoglobulin superfamily that plays an important role in T-lymphocyte activation (PubMed:38467718). Acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T-cells together with the CD28 receptor which is constitutively expressed on the cell surface of T-cells (PubMed:12196291). In turn, activates different signaling pathways such as NF-kappa-B or MAPK leading to the production of different cytokines (PubMed:10438913). In addition, CD28/CD80 costimulatory signal stimulates glucose metabolism and ATP synthesis of T-cells by activating the PI3K/Akt signaling pathway (PubMed:12121659). Acts also as a regulator of PDL1/PDCD1 interactions to limit excess engagement of PDL1 and its inhibitory role in immune responses (PubMed:36727298). Expressed on B-cells, plays a critical role in regulating interactions between B-cells and T-cells in both early and late germinal center responses, which are crucial for the generation of effective humoral immune responses (By similarity). (Microbial infection) Acts as a receptor for adenovirus subgroup B.
CD80, CD28LG, CD28LG1, LAB7, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7
Recombinant human CD80 protein (Active) is a Human Fragment protein, in the 35 to 242 aa range, expressed in HEK 293, with >95% purity, < 1 EU/µg endotoxin level and suitable for SDS-PAGE, ELISA, HPLC, FuncS.
Measured by its binding ability in a functional ELISA. Immobilized ab173993 at 2 μg/mL (100 μL/well) can bind Recombinant human CTLA4 protein (ab167727) with a linear range of 0.5-4 ng/mL.
Measured by its binding ability in a functional ELISA. Immobilized ab173993 at 5 μg/mL (100 μL/well) can bind Recombinant Human CTLA4 (biotinylated) protein (ab207136) with a linear range of 0.6-10 ng/mL.
Measured by its binding ability in a functional ELISA. Immobilized Biotinylated Mouse CD28, His, Avitag at 1 μg/mL (100 μL/well) on streptavidin precoated (0.5 μg/well) plate, can bind ab173993 with a linear range of 0.2-2 ng/mL.
Measured by its binding ability in a SPR assay. Immobilized Human CD28, on CM5 Chip can bind ab173993 with an affinity constant of 2.01 μM.
Measured by its binding ability in a functional ELISA. Immobilized ab173993 at 2 μg/mL (100 μL/well) can bind Human CTLA-4, His Tag with a linear range of 0.1-2 ng/mL (QC tested).
pH: 7.4
Constituents: 10% Trehalose, 0.75% Glycine, 0.61% Tris
Costimulatory molecule that belongs to the immunoglobulin superfamily that plays an important role in T-lymphocyte activation (PubMed:38467718). Acts as the primary auxiliary signal augmenting the MHC/TCR signal in naive T-cells together with the CD28 receptor which is constitutively expressed on the cell surface of T-cells (PubMed:12196291). In turn, activates different signaling pathways such as NF-kappa-B or MAPK leading to the production of different cytokines (PubMed:10438913). In addition, CD28/CD80 costimulatory signal stimulates glucose metabolism and ATP synthesis of T-cells by activating the PI3K/Akt signaling pathway (PubMed:12121659). Acts also as a regulator of PDL1/PDCD1 interactions to limit excess engagement of PDL1 and its inhibitory role in immune responses (PubMed:36727298). Expressed on B-cells, plays a critical role in regulating interactions between B-cells and T-cells in both early and late germinal center responses, which are crucial for the generation of effective humoral immune responses (By similarity).
Palmitoylated by ZDHHC20; palmitoylation protects CD80 from ubiquitin-mediated degradation, regulating the protein stability, and ensures its accurate plasma membrane localization.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
B7-1 and B7-2, together with their receptors CD28 and CTLA4, constitute one of the dominant co-stimulatory pathways that regulate T and Bcell responses. Although both CTLA4 and CD28 can bind to the same ligands, CTLA4 binds to B71 and B72 with a 20 100 fold higher affinity than CD28 and is involved in the downregulation of the immune response.
B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.
CD80 also known as B7-1 is a cell surface protein with a molecular weight of approximately 60 kDa. It is expressed on antigen-presenting cells such as dendritic cells macrophages and B cells. The CD80 protein plays a mechanical role in immune response modulation by providing necessary signals for T cell activation and survival. CD80 interacts with receptors CD28 and CTLA-4 on T cells serving as a costimulatory molecule important for productive immune responses.
CD80 plays a significant role in the immune system's ability to distinguish between self and non-self. It belongs to the B7 family and participates in the formation of immunological synapses between T cells and antigen-presenting cells. This interaction is essential for triggering T cell proliferation and cytokine production forming a part of the adaptive immune response. CD80's expression increases in response to pathogen recognition enhancing the immune system's efficiency.
CD80 is integral to the regulation of T cell-mediated immune responses. It is involved in the CD28 co-stimulatory pathway which is vital for T cell activation and function. In this pathway CD80 interacts with proteins like CD28 and CTLA-4 to modulate immune activation and regulate immune tolerance. The proper function of CD80 within this pathway ensures a balanced immune reaction preventing autoimmunity while allowing effective defense against pathogens.
CD80 plays a role in autoimmune conditions and transplantation rejection. Its overexpression or dysregulation can contribute to diseases such as rheumatoid arthritis where it modifies T cell response and inflammation. Additionally CD80 is implicated in organ transplantation influencing graft rejection outcomes due to its role in modulating immune activation. Understanding CD80 interactions with CTLA-4 and CD28 offers insight into these conditions providing potential targets for therapeutic intervention.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Reduced SDS-PAGE analysis of ab173993, stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized ab173993 at 5 μg/mL (100 μL/well) can bind Recombinant Human CTLA4 (biotinylated) protein (ab207136) with a linear range of 0.6-10 ng/mL.
FACS assay shows that ab173993 can bind to 293T cells overexpressing human CTLA4 protein. The concentration of ab173993 is 1 μg/mL.
Immobilized ab173993 at 5 μg/mL (100 μL/well) can bind Biotinylated Human PD-L1, His Tag, Fc Tag (ab246118) with a linear range of 0.02-1.25 μg/mL
Immobilized Human CD28, on CM5 Chip can bind ab173993 with an affinity constant of 2.01 μM as determined in a SPR assay.
Immobilized ab173993 at 2 μg/mL (100 μL/well) can bind Recombinant human CTLA4 protein (Recombinant human CTLA4 protein (Active) ab167727) with a linear range of 0.5-4 ng/mL.
Immobilized Biotinylated Mouse CD28, His, Avitag at 1 μg/mL (100 μL/well) on streptavidin precoated (0.5 μg/well) plate, can bind ab173993 with a linear range of 0.2-2 ng/mL.
ab173993 at 2 μg/mL (100 μL/well) can bind Human CTLA-4, His Tag with a linear range of 0.1-2 ng/mL (QC tested).
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com